Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase

γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of biochemistry and biophysics 2001-01, Vol.385 (2), p.250-258
Hauptverfasser: London, Robert E., Gabel, Scott A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 258
container_issue 2
container_start_page 250
container_title Archives of biochemistry and biophysics
container_volume 385
creator London, Robert E.
Gabel, Scott A.
description γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.
doi_str_mv 10.1006/abbi.2000.2169
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70886859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003986100921696</els_id><sourcerecordid>70886859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMoun5cPUpP3rpO-pGmR78VBD2s5zBNpxhpm5qkC_u7_B_-Jlt2wZOngZdnXmYexs45LDmAuMKqMssEAJYJF-UeW3AoRQypzPbZYorTuJSCH7Fj7z8BOM9EcsiOOE-FBMgX7O2O1tTaoaM-RNjX0f0a2xGDsX1kmwijG-tsj4Gi5_7DVCZYN-c_3_FjOwbsNm20ctj7gYZgavR0yg4abD2d7eYJe3-4X90-xS-vj8-31y-xTjMIMU53Sl2lJLIEhNDYyJJ4UlIhSedZUxRU1ljoEmSSQ5FT1gBpKQlR5A3V6Qm73PYOzn6N5IPqjNfUttiTHb0qQEoh83ICl1tQO-u9o0YNznToNoqDmh2q2aGaHarZ4bRwsWseq47qP3wnbQLkFqDpv7Uhp7w21GuqjSMdVG3Nf92_fumBUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70886859</pqid></control><display><type>article</type><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>London, Robert E. ; Gabel, Scott A.</creator><creatorcontrib>London, Robert E. ; Gabel, Scott A.</creatorcontrib><description>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</description><identifier>ISSN: 0003-9861</identifier><identifier>EISSN: 1096-0384</identifier><identifier>DOI: 10.1006/abbi.2000.2169</identifier><identifier>PMID: 11368005</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alanine - metabolism ; Alanine Transaminase - metabolism ; Aminobutyrates - metabolism ; Animals ; Aspartate Aminotransferases - metabolism ; Binding Sites ; Boron Compounds - chemistry ; Boron Compounds - pharmacology ; Carbon Isotopes ; Cell Division - drug effects ; Cell Line ; Culture Media - chemistry ; Culture Media - pharmacology ; Cysteine - pharmacology ; gamma-Glutamyltransferase - antagonists &amp; inhibitors ; gamma-Glutamyltransferase - metabolism ; Glutamine - analogs &amp; derivatives ; Glutamine - metabolism ; Hydrogen-Ion Concentration ; Kinetics ; Liver ; Magnetic Resonance Spectroscopy ; Oxaloacetic Acid - metabolism ; Protons ; Pyruvic Acid - metabolism ; Rats</subject><ispartof>Archives of biochemistry and biophysics, 2001-01, Vol.385 (2), p.250-258</ispartof><rights>2001 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</citedby><cites>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/abbi.2000.2169$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11368005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>London, Robert E.</creatorcontrib><creatorcontrib>Gabel, Scott A.</creatorcontrib><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><title>Archives of biochemistry and biophysics</title><addtitle>Arch Biochem Biophys</addtitle><description>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</description><subject>Alanine - metabolism</subject><subject>Alanine Transaminase - metabolism</subject><subject>Aminobutyrates - metabolism</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - metabolism</subject><subject>Binding Sites</subject><subject>Boron Compounds - chemistry</subject><subject>Boron Compounds - pharmacology</subject><subject>Carbon Isotopes</subject><subject>Cell Division - drug effects</subject><subject>Cell Line</subject><subject>Culture Media - chemistry</subject><subject>Culture Media - pharmacology</subject><subject>Cysteine - pharmacology</subject><subject>gamma-Glutamyltransferase - antagonists &amp; inhibitors</subject><subject>gamma-Glutamyltransferase - metabolism</subject><subject>Glutamine - analogs &amp; derivatives</subject><subject>Glutamine - metabolism</subject><subject>Hydrogen-Ion Concentration</subject><subject>Kinetics</subject><subject>Liver</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Oxaloacetic Acid - metabolism</subject><subject>Protons</subject><subject>Pyruvic Acid - metabolism</subject><subject>Rats</subject><issn>0003-9861</issn><issn>1096-0384</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LxDAQhoMoun5cPUpP3rpO-pGmR78VBD2s5zBNpxhpm5qkC_u7_B_-Jlt2wZOngZdnXmYexs45LDmAuMKqMssEAJYJF-UeW3AoRQypzPbZYorTuJSCH7Fj7z8BOM9EcsiOOE-FBMgX7O2O1tTaoaM-RNjX0f0a2xGDsX1kmwijG-tsj4Gi5_7DVCZYN-c_3_FjOwbsNm20ctj7gYZgavR0yg4abD2d7eYJe3-4X90-xS-vj8-31y-xTjMIMU53Sl2lJLIEhNDYyJJ4UlIhSedZUxRU1ljoEmSSQ5FT1gBpKQlR5A3V6Qm73PYOzn6N5IPqjNfUttiTHb0qQEoh83ICl1tQO-u9o0YNznToNoqDmh2q2aGaHarZ4bRwsWseq47qP3wnbQLkFqDpv7Uhp7w21GuqjSMdVG3Nf92_fumBUA</recordid><startdate>20010115</startdate><enddate>20010115</enddate><creator>London, Robert E.</creator><creator>Gabel, Scott A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010115</creationdate><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><author>London, Robert E. ; Gabel, Scott A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alanine - metabolism</topic><topic>Alanine Transaminase - metabolism</topic><topic>Aminobutyrates - metabolism</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - metabolism</topic><topic>Binding Sites</topic><topic>Boron Compounds - chemistry</topic><topic>Boron Compounds - pharmacology</topic><topic>Carbon Isotopes</topic><topic>Cell Division - drug effects</topic><topic>Cell Line</topic><topic>Culture Media - chemistry</topic><topic>Culture Media - pharmacology</topic><topic>Cysteine - pharmacology</topic><topic>gamma-Glutamyltransferase - antagonists &amp; inhibitors</topic><topic>gamma-Glutamyltransferase - metabolism</topic><topic>Glutamine - analogs &amp; derivatives</topic><topic>Glutamine - metabolism</topic><topic>Hydrogen-Ion Concentration</topic><topic>Kinetics</topic><topic>Liver</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Oxaloacetic Acid - metabolism</topic><topic>Protons</topic><topic>Pyruvic Acid - metabolism</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>London, Robert E.</creatorcontrib><creatorcontrib>Gabel, Scott A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>London, Robert E.</au><au>Gabel, Scott A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</atitle><jtitle>Archives of biochemistry and biophysics</jtitle><addtitle>Arch Biochem Biophys</addtitle><date>2001-01-15</date><risdate>2001</risdate><volume>385</volume><issue>2</issue><spage>250</spage><epage>258</epage><pages>250-258</pages><issn>0003-9861</issn><eissn>1096-0384</eissn><abstract>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11368005</pmid><doi>10.1006/abbi.2000.2169</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-9861
ispartof Archives of biochemistry and biophysics, 2001-01, Vol.385 (2), p.250-258
issn 0003-9861
1096-0384
language eng
recordid cdi_proquest_miscellaneous_70886859
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alanine - metabolism
Alanine Transaminase - metabolism
Aminobutyrates - metabolism
Animals
Aspartate Aminotransferases - metabolism
Binding Sites
Boron Compounds - chemistry
Boron Compounds - pharmacology
Carbon Isotopes
Cell Division - drug effects
Cell Line
Culture Media - chemistry
Culture Media - pharmacology
Cysteine - pharmacology
gamma-Glutamyltransferase - antagonists & inhibitors
gamma-Glutamyltransferase - metabolism
Glutamine - analogs & derivatives
Glutamine - metabolism
Hydrogen-Ion Concentration
Kinetics
Liver
Magnetic Resonance Spectroscopy
Oxaloacetic Acid - metabolism
Protons
Pyruvic Acid - metabolism
Rats
title Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A07%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Evaluation%20of%20a%20Boronate%20Inhibitor%20of%20%CE%B3-Glutamyl%20Transpeptidase&rft.jtitle=Archives%20of%20biochemistry%20and%20biophysics&rft.au=London,%20Robert%20E.&rft.date=2001-01-15&rft.volume=385&rft.issue=2&rft.spage=250&rft.epage=258&rft.pages=250-258&rft.issn=0003-9861&rft.eissn=1096-0384&rft_id=info:doi/10.1006/abbi.2000.2169&rft_dat=%3Cproquest_cross%3E70886859%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70886859&rft_id=info:pmid/11368005&rft_els_id=S0003986100921696&rfr_iscdi=true